| Ambetter Health Indiana Clinical | Therapeutic Utilization of Inhaled Nitric Oxide | 2026-04-01 |
| BCBS Florida Coverage Guidelines | Assays of Genetic Expression in Tumor (05-86000-26) | 2026-04-01 |
| BCBS Florida Coverage Guidelines | Denosumab Products (Prolia™; Xgeva™ and (09-J1000-25) | 2026-04-01 |
| BCBS Florida Coverage Guidelines | Lecanemab-irmb (Leqembi, Leqembi Iqlik) (09-J4000-41) | 2026-04-01 |
| BCBS Florida Coverage Guidelines | Linvoseltamab-gcpt (Lynozyfic) IV Infusion (09-J5000-27) | 2026-04-01 |
| BCBS Florida Coverage Guidelines | Medical & Surgical Management of Sleep (02-40000-16) | 2026-04-01 |
| BCBS Florida Coverage Guidelines | Myoelectric Prosthetic and Orthotic (09-L0000-07) | 2026-04-01 |
| BCBS Florida Coverage Guidelines | Octreotide Acetate (Sandostatin LAR® Depot, (09-J0000-90) | 2026-04-01 |
| BCBS Florida Coverage Guidelines | Pembrolizumab (Keytruda®, Keytruda Qlex) (09-J2000-22) | 2026-04-01 |
| BCBS Florida Coverage Guidelines | Tocilizumab Products (Actemra and Tyenne (09-J1000-21) | 2026-04-01 |